Roquefort Therapeutics Investor Relations Material
Latest events
H2 2024
29 Apr, 2025
H1 2024
27 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Roquefort Therapeutics PLC
Access all reports
Roquefort Therapeutics PLC is a United Kingdom-based biotechnology company focused on developing novel therapies targeting cancer and autoimmune diseases. The company specializes in discovering and advancing small molecule and RNA-based therapeutics through its proprietary platforms. Its operations span early-stage research, preclinical testing, and strategic collaborations for drug development. Roquefort Therapeutics PLC is headquartered in London, United Kingdom, and its shares are listed on the LSE.
)
)
)